Apotex Health Corp. (TSX:APTX)

Canada · Delayed Price · Currency is CAD

32.28

-0.04 (-0.12%)

At close: Jun 30, 2026

34.50% (1Y)

Market Cap	7.38B
Revenue (ttm)	3.49B +4.2%
Net Income	373.78M
EPS	1.91
Shares Out	228.50M
PE Ratio	16.88
Forward PE	n/a
Dividend	0.20 (0.62%)
Ex-Dividend Date	n/a

Volume	113,753
Open	32.59
Previous Close	32.32
Day's Range	32.10 - 32.64
52-Week Range	24.00 - 34.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Apotex Health

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1974

Employees 6,216

Stock Exchange Toronto Stock Exchange

Ticker Symbol APTX

Full Company Profile

Financial Performance

In fiscal year 2026, Apotex Health's revenue was 3.49 billion, an increase of 4.21% compared to the previous year's 3.35 billion. Earnings were 373.78 million, an increase of 146.39%.

Financial Statements